Gc-Free Raises $700K

Vista-based Gc-Free, a firm developing diagnostic tools to predict risks of colon, prostate, breast and other cancers, has raised $700,000 in an equity funding, according to a regulatory filing by the firm today. Source of the funding was not disclosed. The firm says it currently provides a tool for detecting N-glycolylneuraminic Acid, a non-human molecule that contaminates biopharmaceutical reagents, products and cell lines. More information »